-
All Events
ProMED and COVID-19 - A Q&A With Our Moderator Team19th ICID Research Posters -
All Content TypesAbstractAccredited ActivityAccredited CourseArticle ReviewAudio PodcastCase StudyClinical CaseCurriculumDocumente-BookePosterExternal LectureExternal ViewerIndexed SlideJournal ArticleLearning QuizLive StreamMatching SlidePodcastPPT SharedSelf-Test CaseSession HighlightTechnical VideoVideo SessionWebcast
-
Sort ByRelevance
-
All TopicsAll Topics
Protected by US Patents
About this activity
Discussion Forum (0)
Emergence of Chikungunya: Distribution and Vector Ecology
This webinar was hosted on Tuesday, the 13th of December 2022 at 9:00 - 10:00 am EST.
Chair: Helena Maltezou
Co-Chair: Laura Talarico
Speakers:
Webinar Outline:
Chikungunya is a mosquito borne viral disease caused by the Chikungunya virus (CHIKV), a Togaviridae virus, and is transmitted by Aedes mosquitoes. Clinical symptoms include acute onset of fever, debilitating joint and muscle pain, headache, nausea, and rash, potentially developing into long-term serious health impairments. Chikungunya virus causes clinical illness in 72 – 92% of infected human around 4 to 7 days after an infected mosquito bite. Complications resulting from the disease include visual, neurological, heart and gastrointestinal manifestations; fatalities have been reported in elderly people at higher risk.
Chikungunya outbreaks have been reported in Asia, Africa, the Americas and recently in Europe. Both the medical and economic burden are expected to grow as the CHIKV primary mosquito vectors continue their geographic spread Although there are some candidate vaccines in clinical trials none are licensed. Therefore, chikungunya shall remain a major public health threat.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/bCC4C0IJ
This webinar was hosted on Tuesday, the 13th of December 2022 at 9:00 - 10:00 am EST.
Chair: Helena Maltezou
Co-Chair: Laura Talarico
Speakers:
- Alfonso Rodriguez-Morales
- Nicola Petrosillo
- Kenneth Linthicum
Webinar Outline:
Chikungunya is a mosquito borne viral disease caused by the Chikungunya virus (CHIKV), a Togaviridae virus, and is transmitted by Aedes mosquitoes. Clinical symptoms include acute onset of fever, debilitating joint and muscle pain, headache, nausea, and rash, potentially developing into long-term serious health impairments. Chikungunya virus causes clinical illness in 72 – 92% of infected human around 4 to 7 days after an infected mosquito bite. Complications resulting from the disease include visual, neurological, heart and gastrointestinal manifestations; fatalities have been reported in elderly people at higher risk.
Chikungunya outbreaks have been reported in Asia, Africa, the Americas and recently in Europe. Both the medical and economic burden are expected to grow as the CHIKV primary mosquito vectors continue their geographic spread Although there are some candidate vaccines in clinical trials none are licensed. Therefore, chikungunya shall remain a major public health threat.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/bCC4C0IJ
Emergence of Chikungunya: Distribution and Vector Ecology
Helena Maltezou
Laura Talarico
Alfonso Rodriguez-Morales
Affiliations:
Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia
Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia
Nicola Petrosillo
Kenneth Linthicum
About this activity
Discussion Forum (0)
Emergence of Chikungunya: Distribution and Vector Ecology
This webinar was hosted on Tuesday, the 13th of December 2022 at 9:00 - 10:00 am EST.
Chair: Helena Maltezou
Co-Chair: Laura Talarico
Speakers:
Webinar Outline:
Chikungunya is a mosquito borne viral disease caused by the Chikungunya virus (CHIKV), a Togaviridae virus, and is transmitted by Aedes mosquitoes. Clinical symptoms include acute onset of fever, debilitating joint and muscle pain, headache, nausea, and rash, potentially developing into long-term serious health impairments. Chikungunya virus causes clinical illness in 72 – 92% of infected human around 4 to 7 days after an infected mosquito bite. Complications resulting from the disease include visual, neurological, heart and gastrointestinal manifestations; fatalities have been reported in elderly people at higher risk.
Chikungunya outbreaks have been reported in Asia, Africa, the Americas and recently in Europe. Both the medical and economic burden are expected to grow as the CHIKV primary mosquito vectors continue their geographic spread Although there are some candidate vaccines in clinical trials none are licensed. Therefore, chikungunya shall remain a major public health threat.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/bCC4C0IJ
This webinar was hosted on Tuesday, the 13th of December 2022 at 9:00 - 10:00 am EST.
Chair: Helena Maltezou
Co-Chair: Laura Talarico
Speakers:
- Alfonso Rodriguez-Morales
- Nicola Petrosillo
- Kenneth Linthicum
Webinar Outline:
Chikungunya is a mosquito borne viral disease caused by the Chikungunya virus (CHIKV), a Togaviridae virus, and is transmitted by Aedes mosquitoes. Clinical symptoms include acute onset of fever, debilitating joint and muscle pain, headache, nausea, and rash, potentially developing into long-term serious health impairments. Chikungunya virus causes clinical illness in 72 – 92% of infected human around 4 to 7 days after an infected mosquito bite. Complications resulting from the disease include visual, neurological, heart and gastrointestinal manifestations; fatalities have been reported in elderly people at higher risk.
Chikungunya outbreaks have been reported in Asia, Africa, the Americas and recently in Europe. Both the medical and economic burden are expected to grow as the CHIKV primary mosquito vectors continue their geographic spread Although there are some candidate vaccines in clinical trials none are licensed. Therefore, chikungunya shall remain a major public health threat.
Please take 2 minutes after the webinar to fill out our evaluation form: https://isid.typeform.com/to/bCC4C0IJ
{{ help_message }}
{{filter}}